Stroke Diagnostics and Therapeutics Market - Global Industry Analysis

Table Of Content

Methodology

Free Analysis

A stroke is the medical emergency condition, seen mostly in elderly age patients. Strokes happen when blood flow to brain stops and brain cells begin to die. There are two kinds of stroke which include ischemic stroke and hemorrhagic stroke. Ischemic stroke is the most common type of stroke and is caused by a blood clot that blocks a blood vessel in the brain. The other stroke is called hemorrhagic stroke and is caused by a blood vessel that breaks and bleeds into the brain.

Globally, stroke diagnostics and therapeutics market have been accelerated by the large patient pool. Moreover, increasing the percentage of the geriatric population in western countries especially in Europe is the key driving factor for fueling the growth of stroke diagnostics and therapeutics market. Furthermore, hypertension, atrial fibrillation and coronary heart diseases are the supporting factors which promote the growth of stroke diagnostics and therapeutics market. However, the high cost of treatment directly affects the growth of stroke diagnostics and therapeutics market. Nonetheless, ongoing research and development in the healthcare sector technologies are expected to open growth avenues for the stroke diagnostics and therapeutics market over the years.

Based on diagnostics, the global stroke diagnostics and therapeutics market is segmented into five types: magnetic resonance imaging, computed tomography scan, electrocardiography, carotid ultrasound, cerebral angiography and others.  Magnetic resonance imaging dominates the diagnostic segment of stroke diagnostics and therapeutics market in 2019. Magnetic resonance imaging of the brain is a safe and painless test that uses a magnetic field and radio waves to produce detailed images of the brain and the brain stem.

Based on therapeutics, the global stroke diagnostics and therapeutics market is segmented into four types: tissue plasminogen activator, antiplatelet, antihypertensive, and anticoagulant. Anticoagulant is an immediate treatment given in the emergency room to reduce the likelihood of having another stroke. Anticoagulant prevents blood clots from forming. Injection of tissue plasminogen activator also called alteplase are given to stroke patients. An injection of TPA is usually given through a vein in the arm. This potent clot-busting drug needs to be given within 4.5 hours after stroke symptoms begin.

Based on application, the global stroke diagnostics and therapeutics market is segmented into two types: haemorrhagic stroke and ischemic stroke. Ischemic stroke dominated the application segment of stroke diagnostics and therapeutics market. Ischemic stroke is the most usual type of stroke which is caused by a blood clot that blocks a blood vessel in the brain. The most common cause problem is narrowing of the arteries in the neck or head. This is most often caused by atherosclerosis, or gradual cholesterol deposition in blood vessels.

Based on geographies, the global stroke diagnostics and therapeutics market is segmented into five types: North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. These segments are further bifurcated into the U.S., UK, Germany, France, China, Japan, India, and Brazil. North America held the largest share in the global stroke diagnostics and therapeutics market followed by Europe and Asia-Pacific. This growth of North America was attributed due to high literacy rate and more awareness regarding controlling the symptoms of strokes which include high blood pressure and high blood glucose level. In addition, this region also associated with advance research related to blood monitoring device. The stroke diagnostics and therapeutics market are expected to witness the highest growth in Asia-Pacific region in upcoming years due government initiatives, awareness, increasing demand of anticoagulant drug and excessive increase of health care.

The key participants operating in the global stroke diagnostics and therapeutics market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cordis Corporation, Koninklijke Philips N.V., GE Healthcare, Siemens AG, Stryker Corporation, Genentech, Inc. and Merck & Co., Inc.